These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 15923907)
1. Reducing drug usage and adverse effects. Part III: Cardiovascular disease and hyperlipidemia. Baron M Health Care Food Nutr Focus; 2005 Jun; 22(6):7-11. PubMed ID: 15923907 [No Abstract] [Full Text] [Related]
2. [Drug treatment of hyperlipidemia]. Noseda G Ther Umsch; 1987 Aug; 44(8):578-83. PubMed ID: 3672411 [No Abstract] [Full Text] [Related]
3. Changes in pharmacologic treatment of hyperlipidemia. Crouse JR; Ryu JE; Kahl FR Am J Prev Med; 1989; 5(2):90-4. PubMed ID: 2730796 [TBL] [Abstract][Full Text] [Related]
4. Drug treatment of lipid disorders. Knopp RH N Engl J Med; 1999 Aug; 341(7):498-511. PubMed ID: 10441607 [No Abstract] [Full Text] [Related]
7. Lipid levels and cardiovascular risk in elderly women: a general population study of the effects of hormonal treatment and lipid-lowering agents. Dupuy AM; Carrière I; Scali J; Cristol JP; Ritchie K; Dartigues JF; Gambert P; Ancelin ML Climacteric; 2008 Feb; 11(1):74-83. PubMed ID: 18202967 [TBL] [Abstract][Full Text] [Related]
8. Management of hyperlipidemia: new LDL-C targets for persons at high-risk for cardiovascular events. Balbisi EA Med Sci Monit; 2006 Feb; 12(2):RA34-9. PubMed ID: 16449961 [TBL] [Abstract][Full Text] [Related]
9. Common questions in managing hyperlipidemia. Rosen IM; Sams RW Prim Care; 2006 Dec; 33(4):903-21. PubMed ID: 17169673 [TBL] [Abstract][Full Text] [Related]
10. Hyperlipidemia management in patients with cardiovascular and cerebrovascular disease. J Fla Med Assoc; 1998 Apr; 85(1):26-8. PubMed ID: 9782725 [No Abstract] [Full Text] [Related]
11. [Favorable effects of decreasing lipids in patients with diabetes mellitus]. Gouni-Berthold I; Krone W Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S252-4. PubMed ID: 17139581 [TBL] [Abstract][Full Text] [Related]
12. Improving lipid goal attainment: is it enough? Gotto AM Circulation; 2009 Jul; 120(1):3-5. PubMed ID: 19546383 [No Abstract] [Full Text] [Related]
13. [Drug interactions in the treatment of primary hyperlipoproteinemias using antilipemic drugs]. Haacke H; Kolenda KD Med Klin; 1976 Mar; 71(12):513-7. PubMed ID: 1263999 [No Abstract] [Full Text] [Related]
14. [Controversies and advances in the treatment of hyperlipidemias]. Reza-Albarrán A; Aguilar-Salinas CA Gac Med Mex; 1998; 134(2):253-6. PubMed ID: 9619005 [No Abstract] [Full Text] [Related]
15. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease. Staels B; Maes M; Zambon A Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):542-53. PubMed ID: 18628776 [TBL] [Abstract][Full Text] [Related]
16. Impact of multiple risk factors on coronary artery disease: beyond total cholesterol. Introduction. Gotto AM Am J Cardiol; 1998 Nov; 82(9A):1Q-2Q. PubMed ID: 9819097 [No Abstract] [Full Text] [Related]
17. Prevention: providing lipid management in a large clinical practice. Brown AS Manag Care; 2003 Sep; 12(9 Suppl):16-21. PubMed ID: 14535131 [No Abstract] [Full Text] [Related]
18. [Treatment of hyperlipidemia in patients with coronary heart disease]. Tikkanen MJ; Miettinen T Duodecim; 1992; 108(19):1649-52. PubMed ID: 1366190 [No Abstract] [Full Text] [Related]
19. Clinical inquiries. Should we identify and treat hyperlipidemia in the advanced elderly? Shah K; Rogers J; Britigan D; Levy C J Fam Pract; 2006 Apr; 55(4):356-7. PubMed ID: 16608678 [No Abstract] [Full Text] [Related]
20. Drug therapy for hyperlipidemia. Franklin FA; Margolis S Cardiovasc Clin; 1984; 14(3):265-84. PubMed ID: 6722855 [No Abstract] [Full Text] [Related] [Next] [New Search]